Intradermal Incobotulinum Toxin A for Postbreast Cancer Treatment Asymmetry: A Literature Review and Case Report
2025

Using Botulinum Toxin for Breast Cancer Treatment Asymmetry

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Bugallo Alejandra, Parra Luis Alberto, Amado Andreina Martinez, De la Fuente Victoria, Murúa Evalicia, Garcés Eliana, Parra Andrea Marcela

Hypothesis

Can botulinum toxin improve aesthetic outcomes in breast cancer survivors with post-treatment asymmetry?

Conclusion

The study suggests that botulinum toxin is a viable option for improving breast asymmetry in cancer survivors.

Supporting Evidence

  • Botulinum toxin is commonly used for aesthetic procedures and has therapeutic applications.
  • Breast cancer survivors often experience deformities and asymmetry post-treatment.
  • The literature review included five full-text articles on botulinum toxin applications in breast cancer.

Takeaway

This study shows that a special medicine called botulinum toxin can help make breasts look better after cancer treatment.

Methodology

A systematic review of literature from 2020 to 2024 and a case report of a patient treated with botulinum toxin.

Limitations

The study does not definitively support the application of botulinum toxin in nipple and areola placement due to lack of data.

Participant Demographics

One 53-year-old female breast cancer survivor.

Digital Object Identifier (DOI)

10.1111/jocd.16754

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication